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Advancement in technology for the treatment 
of cancer is growing rapidly. Recently, Varian has 
introduced a new class of linear accelerator referred 
as HalcyonTM (Varian Medical System, CA). This 
platform delivers only flattening-filter-free (FFF) 
photon beam [1–11]. Halcyon is a new clinical lin-
ear accelerator designed with a ring-mounted gan-
try (RDS) enclosed in a bore with single 6 Mega 
Voltage (MV) FFF beam at 800 MU/min dose rate 
[12]. Halcyon’s treatments are true image guided ra-
diation therapy (IGRT) [13]. It is mandatory to add 
a kilo-voltage cone beam computed tomography 
(KV-CBCT) or MV (orthogonal pair or CBCT) im-
aging field in any treatment plan prior to treatment 
approval for actual delivery on Halcyon. The MV 
imaging dose is calculated in the Eclipse (Varian 
Medical System, CA) treatment planning system 
prior to optimization which is added in prescribed 
AbstrAct
background: Varian Medical systems has introduced a new medical linear accelerator called halcyonTM 2.0, which is based on 
the ring delivery system (rDs). It is a true IGrT machine having 6MV FFF photon energy. In addition to the planar and MV-cBcT 
imaging techniques it also has an option of ultra-fast kV-icBcT which enhances the image reconstruction and improves the 
visualization of soft tissue. The field portals are shaped by a unique dual layer MLc with special stacked and staggered design 
which enables high modulation with low radiation leakage. recently, we have commissioned our first halcyon 2.0 machine. 
The aim of this work was to systematically investigate various parameters of a newly installed halcyonTM 2.0 linear accelerator.
Materials and methods: Detailed measurements were conducted as per various guidelines. also, the measurements were 
performed to fulfil the national regulatory requirements. commissioning data of halcyon 6 MV-FFF beam was performed in 
a water tank. For absolute measurements, a 0.6-cc waterproof Farmer chamber and electrometer were used. all relative mea-
surements (pDDs, in-line, cross-line and angular profiles) were performed with 0.0125 cc point chamber.
results: all the tests were within the acceptable limit. Measured data were compared with factory data as well as the existing 
medical linear accelerator of the same category. The obtained results were quite satisfactory.
conclusions: This study summarizes the commissioning experience with halcyon linear accelerator. evaluation of mechani-
cal, radiation safety and dosimetric parameters were performed. The obtained parameters were well below the specified 
tolerance limits.
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dose [12]. Varian provides a representative beam 
data set consisting of central axis percentage depth 
doses (CAPDDs), profiles and output factors. This 
beam data set was used to configure Halcyon’s opti-
mization and dose calculation models (PO & AAA) 
in the Eclipse treatment planning system (TPS).
Halcyon version 1.0 allows only single isocen-
tre per plan, limiting treatment to its maximum 
field size of 28 × 28 cm2, whereas in Halcyon 2.0 
two isocentres per plan can be added to extend the 
treatment length (longitudinal direction) up to 36 
cm. Although the True Beam (Varian Medical Sys-
tem, Palo Alto, CA) is adopted worldwide, recently, 
at our centre we have installed HalcyonTM 2.0 (Var-
ian Medical System, Palo Alto, CA) linear accelera-
tor. Although, limited resources and information 
is available related to commissioning and quality 
assurance of Halcyon Linear Accelerator till date. 
In this article, we have presented the detailed qual-
ity assurance (QA) tests related to radiation safety, 
mechanical, dosimetrical, and MLCs as per various 
published literatures [14–16]. Measured data were 
also compared with factory data and the results 
were quite satisfactory. Baseline data were also gen-
erated to check the day to day variation during the 
use. Daily Machine Performance Check (MPC) is 
a must before commencement of patient’s treat-
ment on the Halcyon, whereas this is optional in 
the True Beam Machine [17–18]. Halcyon machine 
is equipped with a radiation beam stopper, hence 
shielding thickness and room construction cost are 
reduced drastically.
Dosimetric characteristics of the Halcyon treat-
ment unit were systematically evaluated in terms 
of central axis percentage depth dose (CAPDD) 
curves, beam profiles (In line, Cross line and Diago-
nal), output factors, multi leaf collimators (MLC) 
leakage and MLC quality assurance (QA) [19–22]. 
High-resolution diode detectors and ion chambers 
were used to measure dosimetric data for a range 
of field sizes from 2.0 × 2.0 to 28.0 × 28.0 cm2. It 
is a true IGRT (Image Guided Radiation Therapy) 
machine equipped with single 6 MV-FFF beam at 
800 MU/min fixed dose rate. In addition to the 
planar and MV-CBCT imaging techniques it has an 
option of ultra-fast kV-iCBCT which enhances the 
image reconstruction and improves the visualiza-
tion of soft tissue [23]. The field portals are shaped 
by a unique dual layer MLC with special stacked 
and staggered design which enables high modula-
tion with very low radiation leakage. In Halcyon 
linear accelerator, the × and Y jaws are absent. 
There is no field light, optical distance indicator 
(ODI) and internal lasers for setup. Verification of 
source to skin distance (SSD) or isocentre matching 
has to be performed by acquiring MV orthogonal 
images. Only external laser is provided to set the 
patients/phantom on the couch.
Materials and methods
equipment
HalcyonTM 2.0 is a fixed 6 MV-FFF beam lin-
ear accelerator, mounted opposite to a beam stop-
per in a ring geometry enclosed with carbon fibre 
bore. No bending magnet is used. Halcyon beam 
is shaped entirely with dual layer independently 
functioning new generation multi-leaf collimators 
(MLCs) with stacked and staggered design. The 
design of MLC offers more efficient treatment and 
reduced interleaf leakage. Each leaf is 1.0 cm wide 
projected at the isocenter, and the proximal and 
distal MLC banks are staggered by 0.5 cm to each 
other. Hence, the effective resolution of leaf width 
at isocentre is 0.5 cm. The proximal layer has 29 
pairs of leaves whereas the distal layer has 28 pairs. 
The maximum speed of Halcyon MLCs is 5 cm/sec 
and gantry is 4 times faster than the existing True 
Beam machine (15 versus 60 second for one full 
rotation).  Distance from external laser center to 
the actual physical radiation isocenter is fixed. This 
shift can be verified through the Machine Perfor-
mance Check (MPC), which is compulsory to do 
daily before any treatment to be initiated. 
There is no isocentric motion of the couch in this 
machine, only linear motions are provided. Setting 
the dosimetry equipment at the machine isocentre 
is a tricky job as there is no field light, ODI and 
internal lasers. Setup is performed by first align-
ing the chamber/radiation field analyzer (RFA) to 
external lasers mounted on the front panel of the 
bore, and then loading to the beam center through 
a pre-determined couch shifts. Chamber position 
and water level is verified or adjusted using orthog-
onal MV image pairs. Digital megavoltage imager 
(DMI-aSi1200) is fixed at 154 cm from the source 
in the gantry ring just above the MV beam stopper. 
Imager has a 43 × 43 cm2 field of view (FOV) with 
a 1280 × 1280 pixel matrix and image acquisition 
rate of 25 frames/second at full resolution. 
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Commissioning data of Halcyon 6 MV-FFF 
beam was performed in a water tank (3D Scan-
ner, Sun Nuclear Corporation (SNC, USA). For ab-
solute measurements, a 0.6-cc waterproof Farmer 
chamber (SNC600) and electrometer (Sun Nuclear, 
USA) calibrated at MD Anderson Dosimetry Labo-
ratory, USA were used. All relative measurements 
(CAPDDs, In-line cross-line and angular profiles) 
were performed with 0.0125 cc point chamber 
(SNC 125).  The corrections for effective point of 
measurement were applied. 
calibration of halcyon unit
The Halcyon system software requires the user to 
select one of the three geometries for which 1 MU 
is normalized to 1 cGy. Calibration of the machine 
is restricted to these three different geometries 
and associated dose rates. This can be confirmed 
by measuring the dose to the reference point for 
a 10 × 10 cm2 field size:
• 100 cm SSD, 1.3 cm depth (dmax), max dose rate: 
800 MU/min; 
• 95 cm SSD, 5.0 cm depth, max dose rate: 740 
MU/min;
• 90 cm SSD, 10.0 cm depth, max dose rate: 600 
MU/min. 
It is extremely important that the selected calibra-
tion geometry on the machine and in the treatment 
planning system (TPS) are the same, otherwise, it 
may lead to major treatment error. We have cali-
brated our machine according to the first setting.
Output factors and surface dose
Output factors (OF) were acquired using 
a SNC600 farmer type cylindrical ion chamber for 
field sizes ranging from 2 × 2 to 28 × 28  cm2 . For 
smaller field sizes (≤ 4 × 4 cm2) a small volume 
chamber was also used (SNC125) to correct the 
volume effect. OFs were normalized to a 10 × 10 
cm2 field size. Percentage surface dose (PSD) was 
determined using an edge detector (SNC, USA) for 
the maximum field size.
Mechanical tests
Mechanical tests of the couch, gantry and col-
limator were performed in accordance with rec-
ommendations from standard clinical linear accel-
erators commissioning protocols of the national 
regulatory body. 
radiation dosimetry tests
To evaluate various dosimetry parameters cen-
tral axis depth dose, inline, cross-line and diagonal 
profiles were needed for various field sizes. CAPDD 
profiles were taken for the field sizes ranging from 
2 × 2 to 28 × 28 cm2  with the interval of 2 and were 
determined by MLC settings (as there are no jaws 
in the machine). In-plane and cross-plane profiles 
were taken for the above mentioned field sizes at 
1.3 cm (dmax), 5 cm, 10 cm, 20 cm and 30 cm depths. 
The chamber position was corrected for the effec-
tive point of measurement in the acquisition soft-
ware. Chamber polarity (kpol) and saturation (ks) 
correction factors were also determined. 
Beam quality specifiers (TPR20/10) and PDD 
(10)x were determined in accordance with TRS-398 
[24] and TG-51 [25] protocol, respectively.  PDD 
data at various depths and field sizes were tabulated 
and compared. Penumbra was quantified and com-
pared to other Halcyon machines for the transverse 
and radial beam profiles. For FFF beams, however, 
the penumbra definition of the spatial distance be-
tween the 80% and 20% values does not apply, and 
the normalization technique introduced by Pönisch 
et al. [26] was employed. The penumbral widths 
were quantified after rescaling the FFF beam pro-
files to the ratio of the dose values at the inflection 
points in the penumbral regions between the flat-
tened (FF) and un-flattened (FFF) beams.
Dynamic MLc tests
Average and maximum MLC transmission were 
measured using a farmer-type ionization chamber 
(collecting volume = 0.60 cm3) at nominal treat-
ment distance (NTD). According to TG-50 [27], 
the average leaf transmission should be < 2%. Ac-
curacy of positioning and leaf speed modulation of 
MLC was verified in both the static and dynamic 
mode of delivery, using Picket fence tests [28]. Elec-
tronic portal imaging device (EPID) was used in 
the measurements.
radiation safety
Halcyon unit has a ring-mounted 6 MV-FFF 
linear accelerator with a beam-stopper. The head 
leakage specification is 0.1% and the beam stopper 
is specified for 0.1% transmission of 6 MV. Vault 
shielding evaluation and associated considerations 
were carried out as per the national regulatory body 
and also with reference to NCRP Report No. 151 
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[29]. The head leakage measurements were also 
carried out in patient plane and other than patient 
plane. Radiation area survey is also carried out after 
successful installation of the unit.
results
Mechanical tests
Mechanical tests on the couch and multi leaf 
collimators (MLC) were performed. All the param-
eters were well below their tolerance values speci-
fied by the national regulatory body. The test results 
were consistent with the other Halcyon machine as 
well as with available literature.
couch
Mechanical tests were performed on the Halcyon 
couch. All the obtained parameters were tabulated 
in Table 1. All the parameters were well below the 
specified tolerance limit. Some of the mechanical 
tests on the couch were not applicable to the Hal-
cyon machine. ODI test could not be performed as 
the machine does not have any optical field light. 
The couch rotational accuracy was also not per-
formed as the motion is limited to only vertical, 
lateral and longitudinal directions. 
collimator
Mechanical tests were also performed on MLCs 
and the obtained results were tabulated in Table 2. 
Some of the mechanical tests of MLCs were not ap-
plicable to the Halcyon machine. All the measured 
parameters were well below their specified toler-
ance limit.
calibration of the halcyon unit
Absorbed dose at reference depth in water was 
determined according to the TRS-398 protocol 
[24]. SSD setup (100 cm at water surface) was used 
and 1 MU is normalized to 1 cGy for the refer-
ence field size of 10 × 10 cm2. Alignment of the ion 
chamber at the reference depth was verified with 
orthogonal images of MV-EPID.
Output factors and surface dose
After correction in setup conditions for small 
fields, minimal variation was observed among 
relative photon output factors. Figure 1 shows the 
output factors plotted for various field sizes. The 
green line in the figure indicates the raw output 
factor obtained using a 0.6 cc farmer chamber 
plotted against field size. The output factor for 
small field size is seen to have considerable varia-
table 1. Mechanical tests parameters of couch
Sr. no. Tests Tolerance Observations
1. Minimum level of table top above the floor ≤ 80 cm 62.5 cm
2. Longitudinal motion of the couch ≥ 70 cm 165.5 cm
3. Vertical motion of couch from the isocenter > 40 cm below the isocenter 47.4 cm below the isocenter
4. Minimum linear speed of table top ≤ 1 cm/sec 0.43 cm/sec
5. accuracy of longitudinal motion of table top 0.3 cm for speed ≤ 2.5 cm/sec < 0.1 cm
6. accuracy of lateral motion of the table top 0.3 cm for speed ≤ 2.5 cm/sec < 0.1 cm
7. accuracy of vertical motion of table top 0.3 cm for speed ≤ 2.5 cm/sec < 0.1 cm
8.
Table top sag at isocenter when loaded with 135 kg 
distributed over 2 cm through isocenter
≤ 2 mm ≤ 2 mm
9. couch transmission 0.9798 0.9796
table 2. Mechanical tests parameters of multi leaves collimator (MLc)
Sr. no. Tests Tolerance Observations
1. accuracy of angular scale of collimator 0.5° at ≤ 1°/sec 0.1°
2. Gap between isocenter and end of accessory mount ≥ 30 cm 50 cm
3. shift in isocenter due to collimator rotation ≤ 2 mm in dia 0.6 mm
4. accuracy of leaf position ± 1 mm 0.11 mm
5. reproducibility of leaf position ± 1 mm 0.58 mm
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tion from the predicted data. This deviation is due 
to the large size of the detector volume and lack 
of electronic equilibrium. The purple line shows 
the output factor plotted against the field size 
after applying the correction which was derived 
using a method called Daisy Chaining [14]. The 
measured percentage surface dose for the maxi-
mum field size (28 × 28 cm2) was 63.55% using 
the edge detector and normalised to the depth of 
maximum dose.
radiation dosimetry tests
energy stability check (Tpr20/10)
The energy check was carried out in a water tank 
(RFA system). Table 3 shows the consistency of 
TPR20/10 values measured at different time in a day 
with a coefficient of variation (CoV) of 0.2576. 
Output constancy
Temporal output stability was reported for Hal-
cyon 6-FFF photon beam from the date of com-
missioning. Output at different time in a day was 
measured and tabulated (Tab. 4). No significant 
variation in output was observed during the differ-
ent time in a day. The calculated value of coefficient 
of variation was 0.0872. The central axis output 
measurements over a period of 6 months were also 
analysed and plotted (Fig. 2). The trend of the graph 
demonstrates the normal behaviour with time. The 
observed maximum deviation in output was 0.6% 
from the institutional baseline limit of ±1% with the 
normal calibration. 
consistency in percentage depth dose
Mean energy levels of FFF beams are lower than 
those of corresponding flattened beams. We have 
















T1 (10 aM) 34.803 1.0007 ref
1.0032 0.000876 0.08728
T2 (12 Noon) 34.87 1.0026 0.19
T3 (3 pM) 34.833 1.0015 0.14
T4 (6 pM) 34.81 1.0008 0.01













T1 (10 aM) 0.6267 ref
0.6247 0.001609348 0.257619288
T2 (12 Noon) 0.6245 –0.35
T3 (3 pM) 0.6232 –0.56
T4 (6 pM) 0.6264 –0.05
Figure 1. Output factor of halcyon machine Figure 2. Output constancy check of halcyon machine
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measured the dose at 10 cm depth for the field sizes 
of 5 × 5 and 10 × 10 cm2 for halcyon 6-FFF beam. 
From Table 5 it is observed that the dose at 10 cm 
depth is consistent with the published data of the 
True Beam machine for the same energy [14].
Linearity of MU
Accuracy of radiation dose delivery is limited 
by the dose nonlinearity of smaller MUs. This is 
significant in intensity modulated radiotherapy, 
involving small segment sizes. Linearity was per-
formed over a wide MU range starting from 2 to 
200 MU. This MU range was separated into two 
regions as a small MU range (< 5 MU) and higher 
MU range (> 4 MU). In the small and higher MU 
range, the measured coefficient of linearity (COL) 
was 0.52% and 0.46%, respectively, as shown in 
Table 6 (A and B). These values are much below the 
tolerance limit of 5.0% and 2%, respectively [30]. 
Also from Table 6 it was observed that at the low 
MU range the COL value is higher as compared to 
the higher range. 
Depth dose curves and profiles
For the flattening filter free beams, dmax is lo-
cated closer to the surface than the flattened beams. 
The central axis depth dose curves for Halcyon 
6 MV-FFF beam were measured for various field 
sizes. Figure 3 demonstrates the plot between rela-
tive doses versus field sizes varies from 2 × 2 to 
28 × 28 cm2. Measured value of dmax for Halcyon 6 
MV-FFF beam was 1.3 cm. This is approximately 
2 mm closer to the surface than 6 MV unflattened 
beams. We compared the measured CAPDD curve 
and central axis beam profile with factory data 
(TPS) and found them to be in a good agreement 
as shown in Figure 4. 
 The profiles of unflattened beams have their 
maximum dose on the central axis and decrease 
table 6Ab. MU linearity tests
A. For > 4 MU





1 5 0.597 0.1194
2 6 0.714 0.1190
3 7 0.833 0.1190
4 8 0.948 0.1185
5 9 1.071 0.1190
6 10 1.187 0.1187
7 15 1.777 0.1184
8 20 2.369 0.1184
9 30 3.55 0.1183
10 50 5.917 0.1183
11 70 8.287 0.1184
12 100 11.83 0.1183
13 150 17.74 0.1183

















coefficient of linearity (%) 0.5214
table 5. consistency of pDD at 10 cm depth for 5 × 5 and 10 × 10 cm2 field sizes
Field size Energy Sr. no.
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gradually toward the field edge. This effect becomes 
more pronounced with increasing beam energy and 
field size. We have measured the in-line, cross-line 
and diagonal profiles for 6 MF-FFF beam of Hal-
cyon machine. The profiles at various field sizes and 
depths were plotted and shown in Figure 5. Small-
er variations in profile with depth were observed 
with Halcyon FFF beam. Various parameters, such 
as symmetry and penumbra, were evaluated for 
small as well as large field sizes. For small field size 
(3 × 3 cm2) consistency in symmetry was observed 
and tabulated (Tab. 7). No significant variation in 
symmetry value was noted for both in-line and 
cross-line profile. 
Table 8 summarises the symmetry and penum-
bra obtained for field sizes 5 × 5, 10 × 10, 20 × 20 
and 28 × 28 cm² both in-plane and cross-plane 
geometry at 10 cm depth. From the table it was 
observed that the penumbra for Halcyon is sharper 
for both the in-line and cross-line plane in contrast 
to other existing traditional Clinac machines with 
the same 6 MV-FFF energy [14]. A slight widening 
of the penumbra with increasing field size was ob-
served. The arrangement of jaws at different levels 
in the linear accelerator head causes the difference 
in the penumbra value. The replacement of jaws 
with dual layer MLC in Halcyon, results in ap-




The measured percentage values of the maxi-
mum and average MLC transmission were 0.03% 
and 0.01%, respectively. The maximum and average 
percentages of head leakage in the patient and other 
than patient plane were 0.01%, 0.004% and 0.11%, 
0.02%, respectively.
DMLc output with gantry angle
In this test, the machine output was measured 
at gantry angles of 0, 90, 180 and 270 degrees. At 
each gantry angle, the RapidArc DMLC QA plan 
was performed with a 4 × 28 cm2 DMLC field and 
0.5 cm slit size. Total 300 MU was delivered at the 
dose rate of 800 MU/min. The obtained output 
measurements were summarised in Table 9. The 
obtained values were well below the tolerance 
limits.
Figure 3. pDD curve at various field sizes of halcyon 6 MV-FFF 
beam
Figure 4. Measured versus Tps comparison of pDD curve (Lt) and profile (rt) for 10 × 10 cm2 field size
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Figure 5. In-line and cross-line profiles at various field sizes
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static and dynamic picket fence
For static picket fence 300 MU at the dose rate of 
800 MU/min was delivered, whereas 480 MU was 
used at same dose rate for rotational version of it. 
Fences were shaped with slit opening of 0.1 cm, 10 
pickets in all and 1.5 cm gap between each other. 
Also, the intentional errors were introduced and 
evaluated. All the corresponding images of fences 
were displayed in Figure 6 (A–F). Shaping was done 
by distal leaves (proximal leaves retracted). 
Fences were displayed in the central part of the 
field between × = –7 cm and × = +7 cm. Quantita-
tive and qualitative study was performed on the ob-
tained Picket Fence images. The obtained static and 
dynamic fence results were summarised in Table 10 
and 11, respectively. From the table it was observed 
that the values were well below their tolerance limit.
Discussions
This study summarizes the commissioning expe-
rience of Halcyon linear accelerators. Evaluation of 
mechanical, radiation safety, dosimetric and MLC 
parameters were performed. The obtained param-
eters were well below the specified tolerance limits. 
Results also demonstrated the excellent agreement 
with the other Halcyon machine as well as with 
published results [31–32]. MLC transmission and 
head leakage values showed a drastic reduction in 
radiation leakage and also secondary malignancies 
[22]. This reduction is due to the Halcyon’s new 
generation MLCs. The new generation high speed 
MLCs and improved version of imaging systems 
enhance the accuracy of treatment delivery and 
quality of care. MV as well as KV images are used 
table 9. DMLc output at various gantry angle
Gantry angle (degrees) Relative output Deviation (%) Tolerance (%)
0 (ref ) 0.2903 0.00
90 0.2927 0.8267 ±3%
180 0.2922 0.6545 ±3%
270 0.2928 0.8612 ±3%
table 7. consistency of symmetry for 3 × 3 cm at 10 cm depth













table 8. symmetry and penumbra analysis of various field sizes
No. Photon beam energy Field Size Symmetry Penumbra
1 6 MV FFF 5 × 5 cm Inline/crossline: 0.64%/0.36%
Inline: –4.5 mm, +4.6 mm 
crossline: –4.5 mm, +4.2 mm
2 6 MV FFF 10 × 10 cm Inline/crossline: 0.26%/0.22%
Inline: –4.3 mm, +4.1 mm   
crossline –4.5 mm, +4.3 mm
3 6 MV FFF 20 × 20 cm Inline/crossline: 0.34%/0.35%
Inline: –4.9 mm, +4.8 mm  
crossline –5.2 mm, +4.9 mm
4 6 MV FFF 28 × 28 cm Inline/crossline: 0.64%/0.52%
Inline: –5.5 mm, +5.2 mm  
crossline –5.7 mm, +5.2 mm
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to verify the  positional accuracy of the patient on 
the treatment couch on a day to day basis. In the 
absence of light field, optical-distance-indicator 
and mechanical distance measuring instruments 
which are present and used in Clinac series linear 
accelerators, accurate positioning of a water tank, 
solid water phantoms, detectors as well as patients 
relies on the Halcyon couch largely on the acquired 
MV and KV images.
















179 to 187 0.62 1
Figure 6. picket fence test images at: A. 0°; b. 90°; c. 270°; D. 180° gantry angles; E. During rapidarc delivery (179° to 187° gantry); 
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Halcyon 2.0 offer both megavoltage (MV) as well 
as kilovoltage (KV) imaging systems with advanced 
iCBCT which make images less noisy and provide 
a better visualization of soft tissues. The KV im-
ager in Halcyon2.0 is fixed perpendicular to the 
treatment beam axis as usual. Halcyon’s CBCT has 
limited field size of 28 cm in length and 50 cm field 
of view (FOV). There are some limitations with 
Halcyon 2.0, such as the size of the treatment field 
portal and respiratory gating. We hope these limi-
tations could be addressed in future versions with 
the capability of treating a spectrum of patients who 
need radiotherapy. Commissioning of Halcyon2.0 
linear accelerator presents new challenges related 
to its completely new type of setup geometry and 
the absence of a light field and mechanical dis-
tance measuring devices. A new method was used 
to position the water phantom and other dosimetry 
equipment on the couch top. 
Eclipse treatment planning system for Halcyon is 
preloaded with a representative beam model. Var-
ian provided beam data consist of PDDs curve, 
central axis beam profiles and output factors. As 
the system is preloaded, the need for generating 
extensive beam data sets during the commissioning 
process could be reduced. It is our first experience 
with the Halcyon, hence, we collected a vast data set 
during commissioning. That includes safety data, 
dosimetry data, mechanical data and imaging (MV 
& KV) QA data set. We analysed and compared the 
measured versus representative beam data set pro-
vided by Varian and found no major disagreements. 
We also compared it with the other institute’s Hal-
cyon’s commissioning data sets. It was observed 
that both were in good agreement. The user cannot 
edit/modify or fine-tune the beam data model with 
respect to the measured data set. Instead of editing 
the Eclipse beam data library, the user has to tune 
the Halcyon machine to perform as per TPS data. 
The preconfigured systems have opened a new par-
adigm for Medical Physicists on how to approach 
the subject of acceptance testing, commissioning 
and day to day quality assurance of new generation 
medical linear accelerators.
conclusions 
Parameters related to mechanical, radiation 
safety, dosimetrical and multi-leaf collimators of 
Halcyon’s 6 MV-FFF beams were systematically 
measured. The central axis depth dose curve, beam 
profiles, relative output factors, DMLC parameters 
and other dosimetric data were systematically anal-
ysed. The measured commissioning data show con-
sistency and are in a good agreement with the other 
units with the same energy. The commissioning 
data provided us with valuable insights and reliable 
evaluations on the characteristics of the new gener-
ation treatment delivery system. The systematically 
measured data might be useful for future reference.
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